Latest News

Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma

July 14th 2025

For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.

Living on Borrowed (or Bought) Radiological Time
Living on Borrowed (or Bought) Radiological Time

July 14th 2025

Diagnostic Imaging's Weekly Scan: July 6 — July 12
Diagnostic Imaging's Weekly Scan: July 6 — July 12

July 12th 2025

CCTA Study: Plaque Burden Offers No Prognostic Benefit for Predicting Cardiac Events in Patients with Acute Chest Pain
CCTA Study: Plaque Burden Offers No Prognostic Benefit for Predicting Cardiac Events in Patients with Acute Chest Pain

July 11th 2025

Can AI Enhance Ultrasound Detection of Cardiac Amyloidosis? What a Multicenter Study Reveals
Can AI Enhance Ultrasound Detection of Cardiac Amyloidosis? What a Multicenter Study Reveals

July 11th 2025

Video Interviews

Latest Conference Coverage

View All
Highlighted Interviews from SNMMI 2025
Highlighted Interviews from SNMMI 2025

July 7th 2025

SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome

July 3rd 2025

Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
Improving Access to Nuclear Medicine: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD

June 30th 2025

SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level

June 26th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.